Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 3
2018 1
2019 4
2020 6
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Cancer specific risk in multiple sclerosis patients.
Kyritsis AP, Boussios S, Pavlidis N. Kyritsis AP, et al. Crit Rev Oncol Hematol. 2016 Feb;98:29-34. doi: 10.1016/j.critrevonc.2015.10.002. Epub 2015 Oct 9. Crit Rev Oncol Hematol. 2016. PMID: 26481954 Review.
Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach.
Boussios S, Karihtala P, Moschetta M, Abson C, Karathanasi A, Zakynthinakis-Kyriakou N, Ryan JE, Sheriff M, Rassy E, Pavlidis N. Boussios S, et al. Invest New Drugs. 2020 Feb;38(1):181-193. doi: 10.1007/s10637-019-00867-4. Epub 2019 Oct 24. Invest New Drugs. 2020. PMID: 31650446 Review.
PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca".
Boussios S, Karathanasi A, Cooke D, Neille C, Sadauskaite A, Moschetta M, Zakynthinakis-Kyriakou N, Pavlidis N. Boussios S, et al. Diagnostics (Basel). 2019 May 18;9(2):55. doi: 10.3390/diagnostics9020055. Diagnostics (Basel). 2019. PMID: 31109041 Free PMC article. Review.
The Developing Story of Predictive Biomarkers in Colorectal Cancer.
Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N. Boussios S, et al. J Pers Med. 2019 Feb 7;9(1):12. doi: 10.3390/jpm9010012. J Pers Med. 2019. PMID: 30736475 Free PMC article. Review.
Wise Management of Ovarian Cancer: On the Cutting Edge.
Boussios S, Mikropoulos C, Samartzis E, Karihtala P, Moschetta M, Sheriff M, Karathanasi A, Sadauskaite A, Rassy E, Pavlidis N. Boussios S, et al. J Pers Med. 2020 May 21;10(2):41. doi: 10.3390/jpm10020041. J Pers Med. 2020. PMID: 32455595 Free PMC article. Review.
Melanoma of unknown primary: New perspectives for an old story.
Boussios S, Rassy E, Samartzis E, Moschetta M, Sheriff M, Pérez-Fidalgo JA, Pavlidis N. Boussios S, et al. Crit Rev Oncol Hematol. 2021 Feb;158:103208. doi: 10.1016/j.critrevonc.2020.103208. Epub 2020 Dec 28. Crit Rev Oncol Hematol. 2021. PMID: 33383207 Review.
BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N. Boussios S, et al. Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888. Cancers (Basel). 2022. PMID: 36010882 Free PMC article. Review.
International consensus on the initial diagnostic workup of cancer of unknown primary.
van der Strate I, Kazemzadeh F, Nagtegaal ID, Robbrecht D, van de Wouw A, Padilla CS, Duijts S, Esteller M, Greco FA, Pavlidis N, Qaseem A, Snaebjornsson P, van Zanten SV, Loef C. van der Strate I, et al. Crit Rev Oncol Hematol. 2023 Jan;181:103868. doi: 10.1016/j.critrevonc.2022.103868. Epub 2022 Nov 23. Crit Rev Oncol Hematol. 2023. PMID: 36435296 Review.
18 results